Literature DB >> 3385646

Morphine pellet-induced immunomodulation in mice: temporal relationships.

H U Bryant1, E W Bernton, J W Holaday.   

Abstract

Morphine, an alkaloid known for its potent analgetic action, also affects a variety of immunologic functions. In the experiments reported here, the time course for the effect of 75-mg morphine pellet implants on spleen and thymus size and cellularity and in vitro proliferative responses of lymphocytes from male C3H/HeN mice is described. T lymphocyte proliferation in response to concanavalin A (Con A) was not significantly affected at 6 or 24 hr after morphine pellet implantation but was reduced at 48 and 72 hr. B lymphocyte proliferation in response to lipopolysaccharide was more sensitive to morphinization, as the response was reduced at the 24, 48 and 72 hr intervals after implantation of the morphine pellet. No differences in Con A- or lipopolysaccharide-induced proliferation were observed 96 hr after pellet implantation. Interestingly, a slight elevation of Con A-induced proliferation was observed 120 hr after morphine pellet implantation. By contrast with Con A proliferative data, lipopolysaccharide-induced proliferation of lymphocytes from morphine-treated mice was not different from placebo-pelleted mice at 120 hr. A marked atrophy of the spleen and thymus accompanied the reduced splenocyte proliferative responses of morphine-treated mice and was greatest at the 48 to 72 hr postimplantation interval. The attenuation of mitogen-induced proliferative responses and atrophy of immune organs was accompanied by hypothermia and a marked tolerance to the antinociceptive effect of morphine in morphine-pelleted mice at all of the time points that were monitored.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385646

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

1.  Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection.

Authors:  Jessica M Breslow; M Alexandra Monroy; John M Daly; Joseph J Meissler; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

2.  Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.

Authors:  C Gavériaux-Ruff; H W Matthes; J Peluso; B L Kieffer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is μ-opioid receptor-dependent.

Authors:  Jessica M Breslow; Pu Feng; Joseph J Meissler; John E Pintar; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  Microb Pathog       Date:  2010-08-03       Impact factor: 3.738

4.  Depletion and recovery of lymphoid subsets following morphine administration.

Authors:  E Y Zhang; J Xiong; B L Parker; A Y Chen; P E Fields; X Ma; J Qiu; T M Yankee
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection.

Authors:  Pu Feng; Allan L Truant; Joseph J Meissler; John P Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation.

Authors:  Davorka Messmer; Ikusuke Hatsukari; Naoko Hitosugi; Ingo G H Schmidt-Wolf; Pravin C Singhal
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

7.  Immunomodulatory activity of mu- and kappa-selective opioid agonists.

Authors:  D D Taub; T K Eisenstein; E B Geller; M W Adler; T J Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 8.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

Review 9.  [Differential therapeutic aspects of analgesia with oral sustained-release strong opioids: application intervals, metabolism and immunosuppression].

Authors:  K Güttler; R Sabatowski
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

10.  Peptide opioids and morphine effects on inflammatory process.

Authors:  A Mazzone; G Ricevuti; D Pasotti; A Fioravanti; M Marcoli; S Lecchini; A Notario; G M Frigo
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.